Linked Data API

Show Search Form

Search Results

89677
unstar this property registered interest false more like this
star this property date less than 2014-08-29more like thismore than 2014-08-29
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property hansard heading Health Services: Foreign Nationals more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what recent steps he has taken to ensure that foreign nationals pay for healthcare they receive in the UK. more like this
star this property tabling member constituency Windsor more like this
star this property tabling member printed
Adam Afriyie more like this
star this property uin 207406 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-09-05more like thismore than 2014-09-05
star this property answer text <p> </p><p>The Department is working to support the National Health Service to increase the recovery of costs from overseas visitors and migrants. We aim to recover £500 million annually by the middle of the next Parliament, which will be reinvested into the NHS to support the sustainability of NHS frontline services.</p><p> </p><p> </p><p> </p><p>The Department published its Implementation Plan on 14 July 2014 at:</p><p> </p><p> </p><p> </p><p>www.gov.uk/government/publications/recovering-costs-of-nhs-healthcare-from-visitors-and-migrants</p><p> </p><p> </p><p> </p><p>This sets out how the Department will improve the recovery rates from overseas visitors and migrants over the next year. It announced a number of measures to support these efforts but also laid the foundations for additional areas to be looked at as the programme progresses.</p><p> </p><p> </p><p>As part of the programme the Department is starting a programme of financial incentives to support the NHS in identifying chargeable visitors and migrants using the NHS. These incentives recognise the administrative and financial burdens that can face NHS trusts in the recovery process and aim to counter balance these. The implementation plan provides the full detail of these schemes.</p>
unstar this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-09-05T13:16:37.5869544Zmore like thismore than 2014-09-05T13:16:37.5869544Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
1586
unstar this property label Biography information for Adam Afriyie more like this
89678
unstar this property registered interest false more like this
star this property date less than 2014-08-29more like thismore than 2014-08-29
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property hansard heading Crohn's Disease more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what support his Department is giving to King's College London to work on developing the MAP vaccine for Crohn's disease from animal testing to human trials. more like this
star this property tabling member constituency Elmet and Rothwell more like this
star this property tabling member printed
Alec Shelbrooke more like this
star this property uin 207417 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-09-05more like thismore than 2014-09-05
star this property answer text <p>The Department's National Institute for Health Research (NIHR) is not currently funding any Crohn’s vaccine development work at King’s College London.</p><p>The Government has funding mechanisms in place for research and development relating to innovative medicines.</p><p>The NIHR welcomes funding applications for research into any aspect of human health, including Crohn’s disease and vaccines. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p>The NIHR manages the Efficacy and Mechanism Evaluation programme, which bridges the gap between preclinical studies and evidence of clinical efficacy. The aim is to secure the progress of new technologies and interventions through their early clinical trials and onto larger, later clinical trials. The programme is funded by the Medical Research Council (MRC) and the NIHR.</p><p>Other sources of funding include the Biomedical Catalyst, which is a funding programme jointly operated by the MRC and Innovate UK. The programme provides responsive and effective support for the best translational life science opportunities arising. Grants are available to United Kingdom academics and small and medium enterprises seeking to move their research more quickly from discovery to commercialisation.</p><p> </p>
unstar this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property grouped question UIN 207271 more like this
star this property question first answered
less than 2014-09-05T09:54:16.0569103Zmore like thismore than 2014-09-05T09:54:16.0569103Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
3997
unstar this property label Biography information for Alec Shelbrooke more like this
89713
unstar this property registered interest false more like this
star this property date less than 2014-08-29more like thismore than 2014-08-29
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property hansard heading Crohn's Disease more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what support his Department is providing to King's College London to assist the development of the MAP vaccine for Crohn's disease from animal testing to human trials. more like this
star this property tabling member constituency Elmet and Rothwell more like this
star this property tabling member printed
Alec Shelbrooke more like this
star this property uin 207271 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-09-05more like thismore than 2014-09-05
star this property answer text <p>The Department's National Institute for Health Research (NIHR) is not currently funding any Crohn’s vaccine development work at King’s College London.</p><p>The Government has funding mechanisms in place for research and development relating to innovative medicines.</p><p>The NIHR welcomes funding applications for research into any aspect of human health, including Crohn’s disease and vaccines. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p>The NIHR manages the Efficacy and Mechanism Evaluation programme, which bridges the gap between preclinical studies and evidence of clinical efficacy. The aim is to secure the progress of new technologies and interventions through their early clinical trials and onto larger, later clinical trials. The programme is funded by the Medical Research Council (MRC) and the NIHR.</p><p>Other sources of funding include the Biomedical Catalyst, which is a funding programme jointly operated by the MRC and Innovate UK. The programme provides responsive and effective support for the best translational life science opportunities arising. Grants are available to United Kingdom academics and small and medium enterprises seeking to move their research more quickly from discovery to commercialisation.</p><p> </p>
unstar this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property grouped question UIN 207417 more like this
star this property question first answered
less than 2014-09-05T09:54:15.9943529Zmore like thismore than 2014-09-05T09:54:15.9943529Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
3997
unstar this property label Biography information for Alec Shelbrooke more like this
65722
unstar this property registered interest false more like this
star this property date less than 2014-07-03more like thismore than 2014-07-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property hansard heading Motor Vehicles: Smoking more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, pursuant to the Answer of 30 June 2014, Official Report, column 504W, on tobacco packaging, whether he plans to publish draft regulations to outlaw smoking in cars with children present in time for them to be made law before the end of March 2015. more like this
star this property tabling member constituency Stockton North more like this
star this property tabling member printed
Alex Cunningham more like this
star this property uin 203950 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-07-08more like thismore than 2014-07-08
star this property answer text <p>As set out in my previous answer of 30 June 2014, <em>Official Report</em>, column 504W, regulations for making it an offence to smoke in private vehicles carrying children are being drafted at present.</p> more like this
unstar this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-07-08T15:54:31.0950651Zmore like thismore than 2014-07-08T15:54:31.0950651Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4122
unstar this property label Biography information for Alex Cunningham more like this
49202
unstar this property registered interest false more like this
star this property date less than 2014-04-30more like thismore than 2014-04-30
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, when he plans to bring forward draft regulations for the introduction of standard packaging for tobacco products. more like this
star this property tabling member constituency Stockton North more like this
star this property tabling member printed
Alex Cunningham more like this
star this property uin 197385 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-05-06more like thismore than 2014-05-06
star this property answer text <p>Before reaching a final decision on standardised packaging of tobacco products, and in order to ensure that the decision is properly and fully informed, we intend to publish the draft regulations to make sure that intentions are clear, alongside a final short consultation.</p><p> </p><p>This consultation will ask, in particular, for views on anything new since the last full public consultation that is relevant to a final decision. The content and timing of the consultation will be announced shortly.</p><p> </p> more like this
unstar this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-05-06T12:00:00.00Zmore like thismore than 2014-05-06T12:00:00.00Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4122
unstar this property label Biography information for Alex Cunningham more like this
100420
unstar this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property hansard heading Social Services: Pay more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how many meetings officials of his Department have had with officials of the Department for Business, Innovation and Skills on the naming and shaming of social care providers who do not comply with National Minimum Wage legislation; and when he expects such social care providers to be named and shamed for such non-compliance. more like this
star this property tabling member constituency Stockton North more like this
star this property tabling member printed
Alex Cunningham more like this
star this property uin 211603 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-10-29more like thismore than 2014-10-29
star this property answer text <p>During the course of this year, officials from the Department of Health and the Department for Business, Innovation and Skills (BiS) have formally met once for policy discussions on the issue of non-compliance of social care employers with National Minimum Wage legislation. I have also recently written to the Parliamentary Under-Secretary for Employment Relations (Jo Swinson) on this subject.</p><p> </p><p> </p><p> </p><p>The new scheme making it easier to name and shame employers who do not comply with National Minimum Wage legislation came into effect from October 2013 and applies to investigations initiated after that date. HM Revenue and Customs leads on the conduct of investigations and makes recommendations to BiS Ministers on the issue of naming employers found to be in breach. The timing of any naming of social care providers is therefore dependent on the outcome of investigations, and will follow where appropriate.</p><p> </p> more like this
unstar this property answering member constituency North Norfolk more like this
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-10-29T14:40:50.2442406Zmore like thismore than 2014-10-29T14:40:50.2442406Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
4122
unstar this property label Biography information for Alex Cunningham more like this
77415
unstar this property registered interest false more like this
star this property date less than 2014-07-11more like thismore than 2014-07-11
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property hansard heading Idiopathic Pulmonary Fibrosis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how much his Department has spent on research into idiopathic pulmonary fibrosis in each of the last three years. more like this
star this property tabling member constituency Stockton North more like this
star this property tabling member printed
Alex Cunningham more like this
star this property uin 205398 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-07-21more like thismore than 2014-07-21
star this property answer text <p>Expenditure by the Department’s National Institute for Health Research (NIHR) through research programmes, research centres and units, and research fellowships on research on idiopathic pulmonary fibrosis is shown in the following table.</p><p> </p><table><tbody><tr><td><p>2011-12</p><p>£ million</p></td><td><p>2012-13</p><p>£ million</p></td><td><p>2013-14</p><p>£ million</p></td></tr><tr><td><p>0.1</p></td><td><p>0.3</p></td><td><p>0.6</p></td></tr></tbody></table><p> </p><p>Total spend by the NIHR on research on this disease is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on idiopathic pulmonary fibrosis cannot be disaggregated from total CRN expenditure.</p><p> </p> more like this
unstar this property answering member constituency Central Suffolk and North Ipswich more like this
star this property answering member printed Dr Daniel Poulter more like this
star this property question first answered
less than 2014-07-21T16:40:04.7129561Zmore like thismore than 2014-07-21T16:40:04.7129561Z
star this property answering member
3932
star this property label Biography information for Dr Dan Poulter more like this
star this property tabling member
4122
unstar this property label Biography information for Alex Cunningham more like this
78189
unstar this property registered interest false more like this
star this property date less than 2014-07-15more like thismore than 2014-07-15
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property hansard heading Cancer: Older People more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what research (a) his Department and (b) NHS England is undertaking into comparative cancer survival rates for older people in the UK and other European countries. more like this
star this property tabling member constituency Stockton North more like this
star this property tabling member printed
Alex Cunningham more like this
star this property uin 205945 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-07-21more like thismore than 2014-07-21
star this property answer text <p>NHS England has undertaken some initial analysis of the causes of poorer survival rates in older people. This suggests that several issues contribute to poorer survival in older adults. These include the fact that the chances of diagnosis at emergency presentation increase with age and that older patients are more likely to have co-morbidity which may impact on survival during and after surgery. There is also some evidence that access to surgery, chemotherapy and radiotherapy for older patients has historically been worse than for younger patients. Previous work by the National Cancer Equality Initiative and the National Cancer Information Network has identified that cancer treatment rates decline with age.</p><p> </p><p>The International Cancer Benchmarking Partnership has sought to understand how and why cancer survival varies between countries, including among older people. The partnership has generated insight and understanding that will help all partners improve cancer survival outcomes by optimising cancer policies and services.</p><p> </p><p>Evidence from this initiative suggests that late diagnosis and treatment are crucial factors in England having lower survival rates than other comparable countries (i.e. countries with good data collection systems and similar levels of development). We also know that the most important reasons for late diagnosis are low awareness of the signs and symptoms of cancer; and delays in patients presenting to their doctors.</p>
unstar this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-07-21T16:25:08.3033674Zmore like thismore than 2014-07-21T16:25:08.3033674Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4122
unstar this property label Biography information for Alex Cunningham more like this
77416
unstar this property registered interest false more like this
star this property date less than 2014-07-11more like thismore than 2014-07-11
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property hansard heading Idiopathic Pulmonary Fibrosis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking to reduce deaths from idiopathic pulmonary fibrosis. more like this
star this property tabling member constituency Stockton North more like this
star this property tabling member printed
Alex Cunningham more like this
star this property uin 205399 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-07-21more like thismore than 2014-07-21
star this property answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p>
unstar this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property grouped question UIN
205400 more like this
205401 more like this
205402 more like this
star this property question first answered
less than 2014-07-21T16:13:34.3070831Zmore like thismore than 2014-07-21T16:13:34.3070831Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4122
unstar this property label Biography information for Alex Cunningham more like this
77418
unstar this property registered interest false more like this
star this property date less than 2014-07-11more like thismore than 2014-07-11
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property hansard heading Idiopathic Pulmonary Fibrosis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department plans to take to ensure that the 2013 idiopathic pulmonary fibrosis guidelines, drawn up by the National Institute for Health and Care Excellence, are fully implemented. more like this
star this property tabling member constituency Stockton North more like this
star this property tabling member printed
Alex Cunningham more like this
star this property uin 205400 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-07-21more like thismore than 2014-07-21
star this property answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p>
unstar this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property grouped question UIN
205399 more like this
205401 more like this
205402 more like this
star this property question first answered
less than 2014-07-21T16:13:34.3967495Zmore like thismore than 2014-07-21T16:13:34.3967495Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4122
unstar this property label Biography information for Alex Cunningham more like this